IFF

IFF Pharma Solutions Brings New Innovations and Excipient Excellence to CPHI 2024

26 September 2024 – New York, NY, US – IFF (NYSE:IFF) Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for the pharmaceutical and biotech industries. Celebrating this pivotal milestone, IFF will spotlight its latest solutions for nitrosamine mitigation at CPHI 2024, Milan,...

IFF to unveil breakthrough alginate technologies for biomedical innovation at WBC and TERMIS

27 May 2024 – New York, US – IFF (NYSE:  IFF), a global leader in food and beverage, home and personal care and health will unveil groundbreaking study results at upcoming major biomedical conferences. These results highlight how IFF Pharma Solutions NovaMatrix portfolio of ultrapure alginate biopolymers could revolutionise regenerative medicine and 3D cell culture...